Nizar Y Saad

5PUBLICATIONS
9CO-AUTHORS
Gene and molecular therapyMedical biochemistry - proteins and peptides (incl. medical proteomics)Molecular targetsDevelopmental genetics (incl. sex determination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 21, 2026
Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD.

|Dec 09, 2024
Identification of disease-specific extracellular vesicle-associated plasma protein biomarkers for Duchenne Muscular Dystrophy and Facioscapulohumeral Muscular Dystrophy.

Mustafa Bilal Bayazit, Don Henderson, Kim Truc Nguyen

|May 15, 2023
Post-Translational Modifications of the DUX4 Protein Impact Toxic Function in FSHD Cell Models.

Renatta N Knox, Jocelyn O Eidahl, Lindsay M Wallace

|Jun 06, 2022
The DUX4 protein is a co-repressor of the progesterone and glucocorticoid nuclear receptors.

Julieta Quintero, Nizar Y Saad, Sabrina M Pagnoni

|Dec 09, 2021
Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy.

Nizar Y Saad, Mustafa Al-Kharsan, Sara E Garwick-Coppens

Pageof 1

Frequent Collaborators

3 joint publications

Scott Q Harper

2 joint publications

Mustafa Bilal Bayazit

2 joint publications

Kevin M Flanigan

1 joint publications

Ryan L Boudreau